Summary
High single-dose alternate-day prednisolone therapy (ADT) was compared with daily-dose prednisolone therapy (DDT) for treatment of polymyositis. Thirty patients with polymositis were treated with ADT for an average of 33.9 months. The combined number of improvements was 21 out of 30, a response rate of 70%. Side-effects were very rare and mild. On the other hand, 9 of 17 patients treated with DDT for an average 18.5 months improved, a response rate of 53%. The incidence of side-effects was strikingly higher than with ADT. ADT is therefore strongly advocated for treatment of polymyositis to avoid infectious complications and lessen cushingoid side-effects.
This is a preview of subscription content, log in via an institution to check access.
References
Ansell BM (1984) Management of polymyositis and dermatomyositis. Clin Rheum Dis 10:205–213
Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16:193–208
Axelrod L (1976) Glucocorticoid therapy. Medicine 55:39–65
Behan WMH, Barkas T, Behan PO (1982) Detection of immune complexes in polymyositis. Acta Neurol Scand 65:320–324
Bohan A, Peter JB, Bowman RL, Pearson CM (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56:255–286
Bunch TW (1981) Prednisone and azathioprine for polymyositis. Long-term followup. Arthritis Rheum 24:45–48
Cook JD, Trotter JL, Engel WK, Sciabbarrasi JS (1978) The effects of single-dose alternate-day prednisone therapy on the immunological status of patients with neuromuscular diseases. Ann Neurol 3:166–176
Currie S, Saunders M, Knowles M, Brown AE (1971) Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med 60:63–84
Dale DC, Fauci AS, Wolff SM (1974) Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. N Engl J Med 291:1154–1158
Dau PC (1981) Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients. Arch Neurol 38:544–551
Engel AG, Arahata K (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 16:209–215
Engel WK, Lichter AS, Goldi AP (1981) Polymyositis; remarkable response to total body irradiation (Letter to the editor). Lancet I:658
Fauci AS, Dale DC (1975) Alternate-day prednisone therapy and human lymphocyte subpopulations. J. Clin Invest 55:22–32
Fauci AS, Dale DC, Balow JE (1976) Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 84:304–315
Harter JG, Reddy WJ, Thorn GW (1963) Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 269:591–596
Henriksson KG, Sandstedt P (1982) Polymyositis—treatment and prognosis. A study of 107 patients. Acta Neurol Scand 65:280–300
Hollingworth P, Deveretyndall A, Ansell BM, Platts-Mills T, Gumpel JM, Mertin J, Smith DS, Denman AM (1982) Intensive immunosuppression versus prednisolone in the treatment of connective tissue disease. Ann Rheum Dis 41:557–562
Hunder GG, Sheps SG, Allen GL, Joyce JW (1975) Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis. Ann Intern Med 82:613–618
Lane RJM, Hudgson P (1984) Thymectomy in polymyositis. Lancet I:626
MacGregor RR, Sheagren JN, Lipsett MB, Wolff SM (1967) Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med 280:1427–1431
Nishikai M, Reichlin M (1980) Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 8:881–888
Soyka LF (1967) Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen. Am J Dis Child 113:693–701
Streeten DHP (1975) Corticosteroid therapy. Pharmacological properties and principles of corticosteroid use. JAMA 232:944–947
Thorn GW, Lauler DP (1972) Clinical therapeutics of adrenal disorders. Am J Med 53:673–684
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uchino, M., Araki, S., Yoshida, O. et al. High single-dose alternate-day corticosteroid regimens in treatment of polymyositis. J Neurol 232, 175–178 (1985). https://doi.org/10.1007/BF00313897
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00313897